Health Canada
Symbol of the Government of Canada

Institutional links

Drugs and Health Products
Table 2. Classification and distribution of observations made during voluntary inspection phase.
Regulations

Section /
sub-section
Number of observations
Total
Number of observations
Sponsor sites
Number of observations
Qualified Investigator sites
Brief description of the section / sub-section
C.05.010 1 0 1 Clinical trial conducted according to Good Clinical Practice
C.05.010(a) 1 1 0 Protocol clearly described
C.05.010(b) 9 1 8 Clinical trial conducted in accordance with protocol and Regulations
C.05.010(c) 21 8 13 Quality systems and procedures in place for all aspects of the trial
C.05.010(e) 1 0 1 One Qualified Investigator per site
C.05.010(g) 9 3 6 Qualification, education and training of staff
C.05.010(h) 12 1 11 Informed consent obtained in accordance with applicable laws - subject fully informed
C.05.010(j) 9 5 4 Drug to be manufactured according to applicable Good Manufacturing Practices
C.05.011 1 0 1 Labelling requirements
C.05.011(c) 3 2 1 Labelling requirements - Expiration date
C.05.011(1) 23 2 21 Record, handle, and storage of all information
C.05.011(2) 11 1 10 Maintain complete and accurate records to establish that trial conducted in accordance with GCP
C.05.011(4) 7 6 1 Records to be maintained for 25 years
Total 108 30 78